Standalone Operating Profit Reaches 31.9 Billion Won, Up 26.8% YoY
Growth in Green Chemical and Pharmaceuticals
Returns to Profitability on a Consolidated Basis

SK Chemicals posted its highest-ever quarterly sales for the second quarter of this year, driven by steady growth in both its Green Chemical and pharmaceutical businesses. On a consolidated basis, the company also returned to profitability in terms of operating profit.

SK Chemicals Posts Record Quarterly Sales of 479.1 Billion Won in Q2 View original image

According to a disclosure on August 13, SK Chemicals reported standalone sales of 479.1 billion won and operating profit of 31.9 billion won for the second quarter. These figures represent increases of 24.8% and 26.8%, respectively, compared to the same period last year.


Notably, the sales figure marks the largest quarterly result since SK Discovery was established in 2017 and SK Chemicals was spun off as a business entity.


The improved performance was led by both the Green Chemical and pharmaceutical divisions. The Green Chemical business achieved increased sales and operating profit based on stable demand, while the pharmaceutical business contributed to both quantitative growth and improved profitability thanks to strong sales of its main products.


An SK Chemicals official stated, "Despite ongoing internal and external uncertainties, we are sustaining a growth trajectory centered on our core businesses. In the second half of the year, we plan to expand sales of high value-added products in the Green Chemical segment and promote diversification of treatment areas and the expansion of new product pipelines in the pharmaceuticals sector."



Meanwhile, on a consolidated basis, including SK bioscience, the company reported sales of 745.1 billion won and operating profit of 32.3 billion won for the second quarter, marking a return to profitability.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing